Company / Operating Margin
IMMUCELL CORP /DE/ Operating Margin History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-6.2%
FY2025
5-year range
-32.9% / 20.8%
FY2021-FY2025
Trend
+81.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin returned to growth in FY2025 after 3 years of decline, reaching -6.2%.
Based on SEC 10-K filings.
-6.2% in FY2025 with a 10-year CAGR of -5.9%.
Improved from -12.4% to -6.2% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -5.9pp
Key checks
Key Insights
- In FY2025, operating margin increased 81.2% year-over-year.
- Peak operating margin was recorded in FY2016.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -6.2% | +81.2% |
| FY2024 | -32.9% | -165.8% |
| FY2023 | -12.4% | -232.7% |
| FY2017 | 9.3% | -55.0% |
| FY2016 | 20.8% | +6387.9% |
| FY2015 | -0.3% | -107.3% |
| FY2014 | 4.5% | +136.8% |
| FY2013 | -12.4% | +21.3% |
| FY2012 | -15.7% | -33.8% |
| FY2011 | -11.8% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026